title: Invariant natural killer T cells treated with rapamycin or transforming growth factor-β acquire a regulatory function and suppress T effector lymphocytes.
authors: Dipartimento di Biopatologia e Biotecnologie Mediche, University of Palermo, Palermo, Italy.
authors: Giuliana
authors: G
authors: Guggino
authors: Department of Immunoregulation and Immune Intervention, King's College London, London, UK.
authors: Cristiano
authors: C
authors: Scottà
authors: Department of Immunoregulation and Immune Intervention, King's College London, London, UK.
authors: Giovanna
authors: G
authors: Lombardi
authors: Dipartimento di Biopatologia e Biotecnologie Mediche, University of Palermo, Palermo, Italy.
authors: Francesco
authors: F
authors: Dieli
authors: Dipartimento di Biopatologia e Biotecnologie Mediche, University of Palermo, Palermo, Italy.
authors: Guido
authors: G
authors: Sireci
mesh_terms: D000818:Animals; D006801:Humans; D051379:Mice; D055611:Natural Killer T-Cells / Q000187:drug effects / Q000276:immunology*; D020123:Sirolimus / Q000494:pharmacology*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D016212:Transforming Growth Factor beta; D020123:Sirolimus